Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni

Acta Tropica

Volumn 111, Issue 1, 2009, Pages 82-85

  Pica Mattoccia, Livia ^a   Doenhoff, Michael J ^b   Valle, Cristiana ^a   Basso, Annalisa ^a   Troiani, Anna Rita ^a   Liberti, Piero ^a   Festucci, Alfredo ^a   Guidi, Alessandra ^a   Cioli, Donato ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Drug resistance; Genetics; Praziquantel; Schistosoma mansoni; Schistosome strains

Indexed keywords

PRAZIQUANTEL;

CONCENTRATION (COMPOSITION); DOMINANCE; DRUG; DRUG RESISTANCE; GENETIC ANALYSIS; PARASITE; RABIES; RODENT; SURVIVAL;

ANIMAL EXPERIMENT; ARTICLE; CERCARIA (TREMATODE LARVA); CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INHERITANCE; LABORATORY TEST; MALE; MESENTERIC VEIN; MOUSE; NONHUMAN; PROGENY; SCHISTOSOMA MANSONI; STRAIN IDENTIFICATION; SURVIVAL; WORM;

ANIMALS; ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; FEMALE; GENES, DOMINANT; MALE; MICE; PARASITIC SENSITIVITY TESTS; PRAZIQUANTEL; SCHISTOSOMA MANSONI;

MUS; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 67349259362     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.01.012     Document Type: Article

References (22)

1. Botros S.S., and Bennett J.L. Praziquantel resistance. Expert Opin. Drug Discov. 2 Suppl. 1 (2007) S35-S40
2. Botros S., Sayed H., Amer N., El-Ghannam M., Bennett J.L., and Day T.A. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Int. J. Parasitol. 35 (2005) 787-791
3. Caffrey C.R. Chemotherapy of schistosomiasis: present and future. Curr. Opin. Chem. Biol. 11 (2007) 433-439
4. 50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates. Int. J. Parasitol. 34 (2004) 979-987
5. Cioli D., and Pica Mattoccia L. Genetic analysis of hycanthone resistance in Schistosoma mansoni. Am. J. Trop. Med. Hyg. 33 (1984) 80-88
6. Cioli D., Pica-Mattoccia L., and Archer S. Antischistosomal drugs: past, present... and future?. Pharmacol. Ther. 68 (1995) 35-85
7. Cioli D., Pica-Mattoccia L., and Moroni R. Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene. Exp. Parasitol. 75 (1992) 425-432
8. Fallon P.G., and Doenhoff M.J. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 51 (1994) 83-88
9. Fenwick A., and Webster J.P. Schistosomiasis: challenges for control, treatment and drug resistance. Curr. Opin. Infect. Dis. 19 (2006) 577-582
10. Geerts S., and Gryseels B. Anthelmintic resistance in human helminths: a review. Trop. Med. Int. Health 6 (2001) 915-921
11. 2+ channels targets of praziquantel action?. Int. J. Parasitol. 35 (2005) 1-9
12. Ismail M., Metwally A., Farghaly A., Bruce J., Tao L.F., and Bennett J.L. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am. J. Trop. Med. Hyg. 55 (1996) 214-218
13. Liang Y.S., Coles G.C., Dai J.R., Zhu Y.C., and Doenhoff M.J. Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni. Ann. Trop. Med. Parasitol. 95 (2001) 715-723
14. Liang Y.S., Dai J.R., Zhu Y.C., Coles G.C., and Doenhoff M.J. Genetic analysis of praziquantel resistance in Schistosoma mansoni. Southeast Asian J. Trop. Med. Public Health 34 (2003) 274-280
15. Loker E.S. A comparative study of the life-histories of mammalian schistosomes. Parasitology 87 (1983) 343-369
16. Molyneux D.H. Control of human parasitic diseases: context and overview. Adv. Parasitol. 61 (2006) 1-45
17. Osei-Atweneboana M.Y., Eng J.K., Boakye D.A., Gyapong J.O., and Prichard R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369 (2007) 2021-2029
18. Pica-Mattoccia L., Archer S., and Cioli D. Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules. Mol. Biochem. Parasitol. 55 (1992) 167-175
19. Pica-Mattoccia L., and Cioli D. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int. J. Parasitol. 34 (2004) 527-533
20. Stelma F.F., Talla A., Sow S., Kongs A., Niang M., Polman K., Deelder A.M., and Gryseels B. Efficacy and side-effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53 (1995) 167-170
21. Valle C., Troiani A.R., Festucci A., Pica-Mattoccia L., Liberti P., Wolstenholme A., Francklow K., Doenhoff M.J., and Cioli D. Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel. Mol. Biochem. Parasitol. 130 (2003) 111-115
22. William S., Sabra A., Ramzy F., Mousa M., Demerdash Z., Bennett J.L., Day T.A., and Botros S. Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. Int. J. Parasitol. 31 (2001) 1093-1100